The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.
about
Recent advances in the immunopathogenesis of systemic lupus erythematosus.Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.Pathophysiology of inhibitors to factor VIII in patients with haemophilia A.Factor V anticoagulants: clinical, biochemical, and immunological observationsPregnancy and antibody to factor VIII.The properties of immune complexes formed by human antibodies to factor VIII.Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies.Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.Factor VIII inhibitors: a 50-year perspective.Characterization of factor VIII antibodies.Implications of immunologic methods for measuring antihemophilic factor (factor VIII).Factor VIII inhibitors. Etiology, characterization, natural history, and management.Acquired haemophilia and its management.Procoagulant specificity of factor VIII inhibitor.Induction of immune tolerance, the future of the Registry.Coagulation in an agarose gel and its application to the detection and measurement of factor VIII antibodies.Assay of the immune inhibitor in classic haemophilia: application of virus-antibody reaction kinetics.Studies of the antibody on the platelet surface in patients with factor-VIII inhibitors.The relevance of factor VIII inactivation characteristics in the treatment of patients with antibodies directed against factor VIII.The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs.Inhibitor of factor 8 in mild haemophilia.Acquired factor VIII inhibitor in a patient with mycosis fungoides.Acquired haemophilia - a study of ten cases.Screening of F.VIII:C antibodies by an enzyme-linked immunosorbent assay.Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.Epilogue--hemophilia in 1974: theory and practice.Factor VIII antibodies: immunosuppressive therapy.Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.Gamma G4-Globulin Antibody causing Inhibition of Clotting Factor VIII
P2860
Q33824546-102B28A1-3D20-4244-8E98-5ABA572A41FCQ34283513-B6308E16-18D1-42B2-89CA-7D0249CEDBE8Q34636981-C8AFEF18-CF8F-4AC7-B581-6DC5F8344586Q35579514-CE82E60F-03EA-45AD-85D4-503ABAA33474Q36614289-07571414-5903-4E48-BFE3-35A4B482487AQ37048262-904ED619-5CAF-48D9-8789-EBC5230CB197Q37374547-38265498-8E17-4F36-A8D0-BBCA15C57A27Q37378510-7C8A54A9-2839-4BFB-99A6-1CE03807E7B9Q37876956-6D0BB07C-DC39-46A6-9FF6-AC6621D43B56Q39313666-B690327D-0131-48B1-A607-016E2CD9BAE2Q39313674-26AB6F72-1E32-40B1-AC88-77E386D5422EQ39599707-9B7ACC79-3AC5-42FD-AB7D-96626254CA3BQ40602765-A8E71AFB-9B90-4011-BF2D-B450DDCA1B53Q40667936-EF86F591-9077-40DB-9D80-8DDA9FCE456CQ40957261-6C632E72-D8AC-4E50-BC40-13AD39BDBDFDQ43806256-EF5BED6C-1955-440A-818D-3FCDCD1B184CQ45820603-E7AD1E31-7D41-4E75-BE1C-FA759A446FB7Q45855878-7352EF9C-831D-41A2-9ED7-30DF2F87C082Q45857114-45551D01-9F06-4DF0-A526-6682AA67547BQ45857160-BCD79147-1B64-4930-A9FE-6A2AB5F68D81Q45858991-C4C2E07B-5754-48C0-A263-7EB08E5E959FQ45863990-0708C084-1D22-40FC-AA57-DDF6B1F480D3Q45867023-2EADD47C-C176-44BE-8103-D8587E44C45EQ45872651-CD45B483-1646-4CFA-AA85-A6746E6F4FB2Q45878063-43919211-86F0-4718-A444-BCBD4226267AQ45878078-47C214D0-2DCF-4606-BA36-D6547939C9E1Q45878172-D60EB7CC-9DE7-4466-8C71-8C7907EE7367Q45886858-79DB19B2-BD3C-427D-A4D9-3786BDA19866Q59024865-89EB09BA-2FC6-4E7C-966D-C3C268AD9735
P2860
The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.
description
1967 nî lūn-bûn
@nan
1967 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1967 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
name
The immunologic character of a ...... eir interaction with factor 8.
@ast
The immunologic character of a ...... eir interaction with factor 8.
@en
The immunologic character of acquired inhibitors of antihemophilic globulin
@nl
type
label
The immunologic character of a ...... eir interaction with factor 8.
@ast
The immunologic character of a ...... eir interaction with factor 8.
@en
The immunologic character of acquired inhibitors of antihemophilic globulin
@nl
prefLabel
The immunologic character of a ...... eir interaction with factor 8.
@ast
The immunologic character of a ...... eir interaction with factor 8.
@en
The immunologic character of acquired inhibitors of antihemophilic globulin
@nl
P2860
P356
P1476
The immunologic character of a ...... eir interaction with factor 8.
@en
P2093
Shapiro SS
P2860
P304
P356
10.1172/JCI105517
P407
P577
1967-02-01T00:00:00Z